Literature DB >> 26483424

Appendiceal neuroendocrine neoplasms: diagnosis and management.

Krystallenia I Alexandraki1, Gregory A Kaltsas2, Simona Grozinsky-Glasberg2, Eleftherios Chatzellis2, Ashley B Grossman2.   

Abstract

Gastrointestinal neuroendocrine neoplasms (GI-NENs) are increasingly being recognised, while appendiceal NENs (aNENs) currently constitute the third most common GI-NEN. Appendiceal NENs are generally considered to follow an indolent course with the majority being localised at diagnosis. Thus, the initial surgical approach is not that of a planned oncological resection. Due to the localised nature of the disease in the majority of cases, subsequent biochemical and radiological assessment are not routinely recommended. Histopathological criteria (size, mesoappendiceal invasion, Ki-67 proliferation index, neuro- and angio-invasion) are mainly used to identify those patients who are also candidates for a right hemicolectomy. Goblet cell carcinoids are a distinct entity and should be treated as adenocarcinomas. Despite the absence of any substantial prospective data regarding optimal management and follow-up, recent consensus statements and guidelines have been published. The purpose of this review is to overview the published studies on the diagnosis and management of appendiceal NENs and to suggest a possible management protocol.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  appendiceal; appendicectomy; carcinoid; neoplasm; neuroendocrine; right hemicolectomy

Mesh:

Substances:

Year:  2015        PMID: 26483424     DOI: 10.1530/ERC-15-0310

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  12 in total

1.  Management and outcome of an appendiceal collision tumour composed of neuroendocrine and mucinous neoplasms.

Authors:  Adam N Sholi; Katherine D Gray; Alfons Pomp
Journal:  BMJ Case Rep       Date:  2019-07-10

Review 2.  Is there any role for minimally invasive surgery in NET?

Authors:  M Thomaschewski; H Neeff; T Keck; H P H Neumann; T Strate; E von Dobschuetz
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

3.  An unusual case of appendicitis due to appendiceal neuroendocrine tumor in a patient: A case report.

Authors:  Tingting Gao; Weijue Xu
Journal:  Exp Ther Med       Date:  2022-06-22       Impact factor: 2.751

Review 4.  Appendiceal Neoplasms.

Authors:  Quinton M Hatch; Erin W Gilbert
Journal:  Clin Colon Rectal Surg       Date:  2018-09-04

5.  Two rare cases of appendiceal collision tumours involving an appendiceal mucinous neoplasm and carcinoid.

Authors:  Hwee Leong Tan; Grace Hwei Ching Tan; Melissa Teo
Journal:  BMJ Case Rep       Date:  2016-02-01

6.  Clinicopathologic and prognostic features in appendiceal malignancies: does tumor invasiveness matter?

Authors:  Kazım Şenol; Murat Ferhat Ferhatoğlu; Deniz Tihan
Journal:  Turk J Surg       Date:  2019-12-16

7.  A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.

Authors:  Kjell Oberg; Eric Krenning; Anders Sundin; Lisa Bodei; Mark Kidd; Margot Tesselaar; Valentina Ambrosini; Richard P Baum; Matthew Kulke; Marianne Pavel; Jaroslaw Cwikla; Ignat Drozdov; Massimo Falconi; Nicola Fazio; Andrea Frilling; Robert Jensen; Klaus Koopmans; Tiny Korse; Dik Kwekkeboom; Helmut Maecke; Giovanni Paganelli; Ramon Salazar; Stefano Severi; Jonathan Strosberg; Vikas Prasad; Aldo Scarpa; Ashley Grossman; Annemeik Walenkamp; Mauro Cives; Irene Virgolini; Andreas Kjaer; Irvin M Modlin
Journal:  Endocr Connect       Date:  2016-08-31       Impact factor: 3.335

Review 8.  The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors.

Authors:  Anna Malczewska; Beata Kos-Kudła; Mark Kidd; Ignat Drozdov; Lisa Bodei; Somer Matar; Kjell Oberg; Irvin M Modlin
Journal:  Adv Med Sci       Date:  2019-12-13       Impact factor: 3.287

9.  The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN.

Authors:  Krystallenia I Alexandraki; Gregory Kaltsas; Simona Grozinsky-Glasberg; Kira Oleinikov; Beata Kos-Kudła; Angelika Kogut; Rajaventhan Srirajaskanthan; Michail Pizanias; Kalliopi-Anna Poulia; Clara Ferreira; Martin O Weickert; Kosmas Daskalakis
Journal:  Endocrine       Date:  2020-07-24       Impact factor: 3.633

10.  Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine.

Authors:  Małgorzata Fuksiewicz; Maria Kowalska; Agnieszka Kolasińska-Ćwikła; Jarosław B Ćwikła; Łukasz Sawicki; Katarzyna Roszkowska-Purska; Joanna Drygiel; Beata Kotowicz
Journal:  Endocr Connect       Date:  2018-05-03       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.